COL7A1 and recessive dystrophic epidermolysis bullosa: In RDEB, correction of the COL7A1 defect is particularly promising, as it may restore type VII collagen expression, improve wound healing, reduce the number of chronic non-healing ulcers, and thereby lower the long-term risk of cSCC.